Power Law company profile

G1 Therapeutics

Biotech & Life Sciences · Durham, United States · Founded 2008 · IPO 2017 Colt

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Valuation

$364M

Market cap · 2026

Revenue

$83M

Latest reported FY

Investors

10 investors on G1 Therapeutics's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 2 investors entered at this stage

Series B+ 8 investors entered at this stage

Global footprint

Web traffic by country

2.4K monthly visits
across markets

🇺🇸 United States100%

Top 1 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo